These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3435885)

  • 41. Personality and psychological factors in chronic duodenal ulcer. Their interaction with biological parameters.
    Magni G; Rizzardo R; Di Mario F; Farini R; Aggio L; Naccarato R
    Schweiz Arch Neurol Neurochir Psychiatr; 1984; 135(2):315-20. PubMed ID: 6523076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the effects of gastric antisecretory agents in healthy volunteers and patients with duodenal ulcer.
    Howden CW; Jones DB; Burget DW; Hunt RH
    Gut; 1986 Sep; 27(9):1058-61. PubMed ID: 3758819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relapse rates following initial ulcer healing with sucralfate and cimetidine.
    Marks IN; Wright JP; Lucke W; Girdwood AH
    Scand J Gastroenterol Suppl; 1983; 83():53-6. PubMed ID: 6579632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
    Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF
    Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of duodenal ulcer with psychotropic agents to prevent relapse].
    Skuia NA; Antsane GIa
    Vutr Boles; 1986; 25(5):31-3. PubMed ID: 3811327
    [No Abstract]   [Full Text] [Related]  

  • 46. Relapse of duodenal ulcer.
    McCloy R
    Br Med J (Clin Res Ed); 1986 Dec; 293(6561):1569-70. PubMed ID: 3099965
    [No Abstract]   [Full Text] [Related]  

  • 47. [Antisecretory effects of quamatel and gastrocepin in duodenal ulcer: comparison with intragastric pH-metry].
    Sheptulin AA; Okhlobystin AV
    Klin Med (Mosk); 1998; 76(8):38-40. PubMed ID: 9770967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.
    Hamilton I; O'Connor HJ; Wood NC; Bradbury I; Axon AT
    Gut; 1986 Jan; 27(1):106-10. PubMed ID: 3512382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emotion profile and behaviour pattern of patients with active duodenal ulcer compared with acute coronary patients.
    Catipović-Veselica K; Mićunović N; Ilakovac V; Catipović B; Mujić N; Lauc A
    Acta Med Croatica; 1993; 47(2):89-92. PubMed ID: 7505135
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The assessment of the psychophysiological status of patients with duodenal peptic ulcer].
    Ol'khov OG; Pertseva TA; Gerasimchuk ON; Khrustaleva OS; Sokolovskiĭ AV; Baĭbuz TE
    Lik Sprava; 1996; (3-4):120-2. PubMed ID: 9035844
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seasonal behaviour of healed duodenal ulcer.
    Gupta AK; Pal LS
    J Indian Med Assoc; 1998 Apr; 96(4):106-8. PubMed ID: 9844330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of sulglycotide in the prevention of duodenal ulcer relapse.
    De Conca V; Saccomanno S; Dodero M; Aste H
    Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):25-8. PubMed ID: 7866806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Presenting characteristics of patients with duodenal ulcer and outcome of medical treatment in controlled clinical trials using cimetidine and diethylamine persilate to treat ulcer attack and diethylamine persilate and placebo to prevent relapses.
    Bertschinger P; Lacher G; Aenishänslin W; Baerlocher C; Bernoulli R; Egger G; Eisner M; Fasel F; Fehr HR; Fumagalli I
    Digestion; 1987; 36(3):148-61. PubMed ID: 3297895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recurrence of Helicobacter pylori infection and duodenal ulcer relapse, following successful eradication in an urban east Asian population.
    Khor CJ; Fock KM; Ng TM; Teo EK; Sim CS; Tan AL; Ng A
    Singapore Med J; 2000 Aug; 41(8):382-6. PubMed ID: 11256345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A single nocte dose of famotidine in the treatment of duodenal ulcer.
    Qureshi H; Ahmad W; Zuberi SJ
    J Pak Med Assoc; 1989 Apr; 39(4):104-6. PubMed ID: 2568508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori?
    Chan FK; Sung JJ; Lee YT; Leung WK; Chan LY; Yung MY; Chung SC
    Am J Gastroenterol; 1997 Mar; 92(3):442-5. PubMed ID: 9068465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seasonal relapse of healed duodenal ulcer.
    Gupta AK; Pal LS
    J Assoc Physicians India; 1998 May; 46(5):489. PubMed ID: 11273301
    [No Abstract]   [Full Text] [Related]  

  • 58. Intermittent treatment of duodenal ulcer for long term medical management.
    Bardhan KD
    Postgrad Med J; 1988; 64 Suppl 1():40-6. PubMed ID: 2901744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acid, motility, and ulcers: a comparison of cisapride with placebo in the prevention of duodenal ulcer relapse.
    Kerrigan DD; Taylor ME; Read NW; Johnson AG
    Gut; 1993 Aug; 34(8):1042-6. PubMed ID: 8174950
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Individualized treatment of duodenal ulcer disease. A pilot study.
    Di Mario F; Battaglia G; Pasqualetti P; Grassi SA; Leandro G; Vio A; Germanà B; Vianello F; Dotto P; Naccarato R
    Hepatogastroenterology; 1992 Jun; 39(3):273-6. PubMed ID: 1354634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.